137 related articles for article (PubMed ID: 9783492)
21. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Berthet K; Neal BC; Chalmers JP; MacMahon SW; Bousser MG; Colman SA; Woodward M;
Blood Press; 2004; 13(1):7-13. PubMed ID: 15083634
[TBL] [Abstract][Full Text] [Related]
22. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
Arima H; Anderson C; Omae T; Woodward M; Hata J; Murakami Y; Macmahon S; Neal B; Chalmers J;
Stroke; 2011 Aug; 42(8):2339-41. PubMed ID: 21700945
[TBL] [Abstract][Full Text] [Related]
23. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
Bulpitt C; Fletcher A; Beckett N; Coope J; Gil-Extremera B; Forette F; Nachev C; Potter J; Sever P; Staessen J; Swift C; Tuomilehto J
Drugs Aging; 2001; 18(3):151-64. PubMed ID: 11302283
[TBL] [Abstract][Full Text] [Related]
24. Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.
Wing LM; Arnolda LF; Harvey PJ; Upton J; Molloy D; Gabb GM; Bune AJ; Chalmers JP
Blood Press; 1998 Nov; 7(5-6):299-307. PubMed ID: 10321443
[TBL] [Abstract][Full Text] [Related]
25. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.
Gueyffier F; Subtil F; Bejan-Angoulvant T; Zerbib Y; Baguet JP; Boivin JM; Mercier A; Leftheriotis G; Gagnol JP; Fauvel JP; Giraud C; Bricca G; Maucort-Boulch D; Erpeldinger S;
J Hum Hypertens; 2015 Jan; 29(1):22-7. PubMed ID: 24739801
[TBL] [Abstract][Full Text] [Related]
26. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
27. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.
Castaigne A; Chalmers J; Morgan T; Chastang C; Feldmann L; Guez D
Clin Exp Hypertens; 1999 Oct; 21(7):1097-110. PubMed ID: 10513830
[TBL] [Abstract][Full Text] [Related]
29. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
30. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
Huang SS; Wu TC; Lin SJ; Chen JW
Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
[TBL] [Abstract][Full Text] [Related]
31. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
32. Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A; Chapman N; Woodward M; Liu LS; Colman S; Lee A; Chalmers J; MacMahon S;
J Hypertens; 2004 Mar; 22(3):653-9. PubMed ID: 15076173
[TBL] [Abstract][Full Text] [Related]
33. Trials on blood pressure-lowering and secondary stroke prevention.
Chalmers J
Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
[TBL] [Abstract][Full Text] [Related]
34. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
35. Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide.
Myers MG; Asmar R; Leenen FH; Safar M
J Hypertens; 2000 Mar; 18(3):317-25. PubMed ID: 10726719
[TBL] [Abstract][Full Text] [Related]
36. Combination BP therapy cuts second stroke risk in half.
Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
[No Abstract] [Full Text] [Related]
37. Global impact of stroke.
Chalmers J
Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC).
Hasegawa Y; Shimada K; Yamaguchi T
Blood Press Suppl; 2010 Feb; 1():10-6. PubMed ID: 20175714
[TBL] [Abstract][Full Text] [Related]
39. [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial].
Liu LS; Gong LS; Wang W;
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):613-7. PubMed ID: 16080808
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
